Replies to post #406 on Merck and Co Inc (MRK)

[Prudent Capitalist]

Someone is accumulating MRK shares in a very big way, based on the low volume but steady rise in the share price of late. Although it has pulled back today just a bit, the recent accumulation has been obvious and substantial.

[DewDiligence]

FDA approves Keytruda monotherapy in second-line esophageal cancer for PD-L1-positive patients:

https://finance.yahoo.com/news/fda-approves-monotherapy-indication-merck-104500838.html

This approval is based on the KEYNOTE-181 and KEYNOTE-180 studies (the latter included only third-line patients).